Insider · CIK 0001504699
Karen Drexler
Files at RMD (RESMED INC), NONE. (EBR Systems, Inc.), OM (Outset Medical, Inc.). First filing Dec 2, 2025, latest Dec 2, 2025.
Karen Drexler files SEC Form 4 as director at OM (Outset Medical, Inc.), and also at RMD (RESMED INC), NONE. (EBR Systems, Inc.). Since Dec 2, 2025, Karen Drexler has reported 0 open-market buys worth $0 and 1 open-market sell worth $6,765, the latest filed on Dec 2, 2025.
A track record needs three past buys with six months of prices behind them; Karen Drexler has 0, so none is measured yet.
The newest scored trade: sold $6,765 of OM on Dec 1, 2025, filed Dec 2, 2025, scored 35 (weak). In the last 12 months: 0 buys worth $0 and 1 sell worth $6,765.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OM: Outset Medical, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | Outset Medical, Inc. | $6,765 1,548 shares | -13% | 0% from low-80% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 4, 2026 | OM Outset Medical, Inc. | AGrant or award Common Stock | +10,667 | $0.00 | $0 | 21,317 | Jun 5, 2026 |
| May 6, 2026 | NONE. EBR Systems, Inc. | AGrant or award Stock Option (right to buy)derivative | +34,211 | $0.00 | $0 | 34,211 | May 8, 2026 |
| Dec 1, 2025 | OM Outset Medical, Inc. | SOpen-market sale Common Stock | -1,548 | $4.37 | $6,765 | 10,650 | Dec 2, 2025 |
| Nov 20, 2025 | RMD RESMED INC | AGrant or award ResMed Common Stock | +1,073 | $0.00 | $0 | 10,602 | Nov 24, 2025 |
| Jun 2, 2025 | OM Outset Medical, Inc. | AGrant or award Common Stock | +8,983 | $0.00 | $0 | 12,198 | Jun 4, 2025 |
| May 21, 2025 | NONE. EBR Systems, Inc. | AGrant or award Stock Option (right to buy)derivative | +175,781 | $0.00 | $0 | 175,781 | May 22, 2025 |
| Mar 10, 2025 | OM Outset Medical, Inc. | MOption exercise Common Stockindirect: Drexler Family Trust | +31,250 | - | - | 31,250 | Mar 11, 2025 |
| Mar 7, 2025 | OM Outset Medical, Inc. | AGrant or award Series A Non-Voting Convertible Preferredderivativeindirect: Drexler Family Trust | +125 | $200.00 | $25k | 125 | Mar 11, 2025 |
| Mar 10, 2025 | OM Outset Medical, Inc. | MOption exercise Series A Non-Voting Convertible Preferredderivativeindirect: Drexler Family Trust | -125 | $0.00 | $0 | 0 | Mar 11, 2025 |
| Nov 20, 2024 | RMD RESMED INC | AGrant or award ResMed Common Stock | +1,083 | $0.00 | $0 | 9,529 | Nov 22, 2024 |
Questions about Karen Drexler
Answered from the filings on this page, as of the latest one.
Is Karen Drexler buying or selling?
In the last 12 months Karen Drexler reported 0 open-market buys worth $0 and 1 open-market sell worth $6,765 on SEC Form 4; the latest was sold $6,765 of OM on Dec 1, 2025. Grants, option exercises and tax withholding are not counted.
How did Karen Drexler's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Karen Drexler has 0.
Where does Karen Drexler file Form 4?
Karen Drexler has filed Form 4 at OM (Outset Medical, Inc.); RMD (RESMED INC); NONE. (EBR Systems, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.